Influences on physicians' choices of intravenous colloids
Influences on physicians' choices of intravenous colloids
复制标题
DOI：
10.1007/s00134-002-1337-z
复制
发表时间：
2002-07-01
影响因子：
38.9
通讯作者：
Norton, PG
中科院分区：
文献类型：
--
作者：
Miletin, MS;Stewart, TE;Norton, PG
目的：关于容量复苏最佳静脉输液的争论持续不断。我们的目标是描述静脉注射胶体的医生的人口统计学特征，并确定影响他们决定选择胶体的因素。设计：问卷共61项。参与者和环境：加拿大安大略省10% （n=364）的频繁静脉输液处方者。结果：有效率为74%。在过去的一年中，79%的受访医生报告了胶体的使用情况。选择胶体的重要原因包括失血和控制肿瘤压力。医生倾向于选择白蛋白或五星淀粉，但没有发现在两者之间选择的重要原因。在5/13种情况下，超过50%的受访者更倾向于含或不含晶体的白蛋白，而在任何情况下，五分之一的受访者都不喜欢白蛋白。在重症监护领域和教学医院执业的医生通常更喜欢五星淀粉而不是白蛋白。报告称五戊酰胺占胶体总用量90%以上的医生比那些使用较少合成胶体的医生更有可能被五戊酰胺的药物详细人员拜访过(54% vs 22%, p
Objectives: Controversy over the optimal intravenous fluid for volume resuscitation continues unabated. Our objectives were to characterize the demographics of physicians who prescribe intravenous colloids and determine factors that enter into their decision to choose a colloid. Design: Questionnaire with 61 items. Participants and setting: Ten percent (n=364) of frequent intravenous fluid prescribers in the province of Ontario, Canada. Results: The response rate was 74%. Colloid use in the past year was reported by 79% of the responding physicians. Important reasons for choosing a colloid included blood loss and manipulation of oncotic pressure. Physicians tended to prefer either albumin or pentastarch, but no important reasons were found for choosing between the two. Albumin with or without crystalloid was preferred in 5/13 scenarios by more than 50% of the respondents, whereas pentastarch was not favored by more than 50% of respondents in any scenario. Physicians practising in critical care areas and teaching hospitals generally preferred pentastarch to albumin. Physicians reporting pentastarch as representing greater than 90% of total colloid use were more likely to have been visited by a drug detailer for pentastarch than those who used less synthetic colloid (54 vs 22%, p